Pfizer, Moderna win over FDA for second round of COVID-19 boosters in older adultsnews2022-03-29T14:36:31+00:00March 29th, 2022|Fierce Pharma|
Pfizer, Moderna win over FDA for 2nd round of COVID-19 boosters in older adultsnews2022-03-29T14:36:31+00:00March 29th, 2022|Fierce Pharma|
In a busy month, Pfizer extends recall of blood pressure meds to the UKnews2022-03-29T13:07:48+00:00March 29th, 2022|Fierce Pharma|
Vaxxas strikes deal to tee up trial of COVID-19 vaccine patchnews2022-03-29T13:06:10+00:00March 29th, 2022|Fierce Pharma|
On a roll, Sanofi raises Dupixent’s peak sales target to €13B-plusnews2022-03-29T13:02:57+00:00March 29th, 2022|Fierce Pharma|
Sun taps travel for its new ‘long haul’ psoriasis campaignnews2022-03-29T11:05:58+00:00March 29th, 2022|Fierce Pharma|
Roche’s Chugai pays Halozyme $25M to access subcutaneous delivery technews2022-03-29T10:36:52+00:00March 29th, 2022|Fierce Pharma|
Bankruptcy court clears Purdue to fund low-cost opioid rescue medicationnews2022-03-29T10:33:29+00:00March 29th, 2022|Fierce Pharma|
Seeking to shake up eye inflammation market, Optifye and DelSiTech partner on controlled-release dropsnews2022-03-29T10:30:08+00:00March 29th, 2022|Fierce Pharma|
Aurobindo strikes branded generics buyout to build biosimilars ‘launch pad’ in Indianews2022-03-29T10:10:50+00:00March 29th, 2022|Fierce Pharma|
